Communicating computational workflows in a regulatory environment.

BioCompute HTS adventitious virus detection metagenomics next generation sequencing vaccine

Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 31 12 2022
revised: 14 12 2023
accepted: 10 01 2024
medline: 11 3 2024
pubmed: 15 1 2024
entrez: 14 1 2024
Statut: ppublish

Résumé

The volume of nucleic acid sequence data has exploded recently, amplifying the challenge of transforming data into meaningful information. Processing data can require an increasingly complex ecosystem of customized tools, which increases difficulty in communicating analyses in an understandable way yet is of sufficient detail to enable informed decisions or repeats. This can be of particular interest to institutions and companies communicating computations in a regulatory environment. BioCompute Objects (BCOs; an instance of pipeline documentation that conforms to the IEEE 2791-2020 standard) were developed as a standardized mechanism for analysis reporting. A suite of BCOs is presented, representing interconnected elements of a computation modeled after those that might be found in a regulatory submission but are shared publicly - in this case a pipeline designed to identify viral contaminants in biological manufacturing, such as for vaccines.

Identifiants

pubmed: 38219969
pii: S1359-6446(24)00009-6
doi: 10.1016/j.drudis.2024.103884
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103884

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Jonathon G Keeney (JG)

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA. Electronic address: keeneyjg@gwu.edu.

Naila Gulzar (N)

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.

Jack B Baker (JB)

Merck & Co., Kenilworth, NJ, USA.

Ondrej Klempir (O)

R&D Informatics Solutions, MSD Czech Republic, Prague, Czech Republic.

Geoffrey D Hannigan (GD)

Exploratory Science Center, Merck & Co., Cambridge, MA, USA.

Danny A Bitton (DA)

R&D Informatics Solutions, MSD Czech Republic, Prague, Czech Republic.

Julia M Maritz (JM)

Exploratory Science Center, Merck & Co., Cambridge, MA, USA.

Charles H S King (CHS)

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.

Janisha A Patel (JA)

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.

Paul Duncan (P)

Merck & Co., Kenilworth, NJ, USA.

Raja Mazumder (R)

Department of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing
Coal Metagenome Phylogeny Bacteria Genome, Bacterial
Humans Colorectal Neoplasms Biomarkers, Tumor Prognosis Gene Expression Regulation, Neoplastic

Classifications MeSH